Clarium vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $27M Series A led by Northzone with Kaiser Permanente Ventures and General Catalyst. First AI supply chain resiliency platform built specifically for hospital systems.
About
Clarium is the first AI-powered supply chain resiliency platform built specifically for hospital health systems, providing real-time intelligence about supply chain disruptions before they cause care delivery failures. The company raised $27 million in Series A financing led by Northzone, with Kaiser Permanente Ventures, General Catalyst, and Cleveland Clinic participating. A former Kaiser Permanente Chief Supply Chain Officer joined as strategic advisor in Q1 2026.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.